Understanding Indication Specific
Utilization with Projected Data

A global pharma company wanted to understand sub-national usage of a blockbuster IV infusion oncology therapy across >5 indications. The company sought a partner to better contextualize the opportunity and improve field planning and performance reporting. ³Ô¹Ï±¬ÁÏ leveraged longitudinal patient claims data (³Ô¹Ï±¬ÁÏ Compass Patient) and projected patient claims data (³Ô¹Ï±¬ÁÏ Compass Prescriber) to uncover detailed insights of usage patterns by indication, indication-level product performance vs. competitors, and understand the true market landscape and patient opportunity

Approach:

  • Develop Rules and Endpoints: Aligned on indication specific patient cohort definitions and qualification criteria, and identified key business endpoints to guide analysis
  • Construct Patient Cohorts in Compass Patient: Applied business rules to Compass Patient data to construct patient cohorts across the indications
  • Allocate to Projected Data: Optimized the allocation algorithm (Bayesian Model) to leverage insights from Compass Patient to project indication onto the Compass Prescriber data at an HCP / HCO level across indications
  • Determine Indication Level Projections: Outputs included Indication level breakouts for the client¡¯s product and competitors at the HCP, HCO and Zip level

Impact:

  • Enhanced Field Planning & Performance Reporting: Better contextualization of market opportunities and improved effectiveness of field planning and sales performance reporting
  • Projections for Non-Retail ³Ô¹Ï±¬ÁÏ: New visibility into market behavior and trends at the prescriber level for a product which projections previously did not exist given non-retail status of company¡¯s product and competitive products
  • Improved Market Analysis and Visibility: The ability to accurately understand and analyze market share across each specific indication for the product and competitive market basket, providing a competitive advantage

Top Differentiators/Benefits:

  • Retail + Non-Retail: for the first time, customer had a complete view of the market projections in a competitive landscape that included retail and non-retail products through Compass Prescriber
  • Unlimited Access: allowed the team to better understand prescriber patient population and prescribing behavior for improved accuracy of allocation models
  • Speed: ³Ô¹Ï±¬ÁÏ’s proprietary data and standard projection and allocation methodologies enable rapid deployment of analyses, allowing clients to act with speed and agility

See more Compass customer stories.